SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-154338
Filing Date
2023-05-25
Accepted
2023-05-25 16:58:59
Documents
12
Period of Report
2023-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d350381d8k.htm   iXBRL 8-K 29621
  Complete submission text file 0001193125-23-154338.txt   152219

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fdmt-20230523.xsd EX-101.SCH 2898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fdmt-20230523_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fdmt-20230523_pre.xml EX-101.PRE 11290
6 EXTRACTED XBRL INSTANCE DOCUMENT d350381d8k_htm.xml XML 3360
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 23961753
SIC: 2836 Biological Products, (No Diagnostic Substances)